Observational studyNeurology2022

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.

Izanne Roos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.